US 11338028
Cancer vaccines targeting LEMD1 and uses thereof
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 11338028 (Cancer vaccines targeting LEMD1 and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/572, A61K39/001184